Glucose-6-Phosphate Dehydrogenase and 6-Phosphogluconate Dehydrogenase D
Zepbound, which mimics a second hormone called gastric inhibitory polypeptide (GIP) in addition to the GLP-1, comes in an injectable, prefilled, single-use pen for just over $1,000 per pen
Understanding what to expect at each stage of escalation helps you distinguish between normal adaptation and signals that something is wrong
The magnitude of weight loss also raises questions about how early these therapies might be used in disease progression
The most commonly reported issues include nausea (especially during dose increases), gastrointestinal disturbances , reduced sleep quality, elevated resting heart rate (one user noted a 10 bpm increase by week 4), and acid reflux when eating late in the day